The BioAngels Board of Directors

The activities of BioAngels Inc are governed by the Rules of the Association. BioAngels Inc's board of Directors meets 6 times a year.  The following members have been elected and are currently in Office:

John Ballard (Chair)

John Ballard was Managing Director and previously CEO of the GroPep Ltd until 2002, positions he held since the inception of the company in 1988 and through its listing on the ASX in 2000. He was one of the founders of BioAngels, of which he is currently Chairman. He is also a Director of BR-Angels Pty Ltd, Applimex Pty Ltd, AdAlta Pty Ltd and Neubody Pty Ltd as well as the not-for-profit companies, Australian Proteome Analysis Facility Ltd, The Australian Association of Angel Investors Ltd and the Australian Institute for Commercialisation Ltd. He is a biochemist by training (PhD, BSc), has authored more than 300 research publications and is an inventor of 10 patents. He was elected to the Australian Academy of Technological Sciences and Engineering in 1997.

Keith Potts (Treasurer)

Keith Potts is an angel investor in new technology companies, consultant and a company director. He is the director and chairman of Pristine Forage Technologies and a director of Cereal Electricity Pty. Ltd. and Kyna Keju Pty. Ltd. Keith has held executive positions with the CRC CSSIP as Marketing Manager (2000 – 2004) and was a Business Development Manager with CSIRO, manufacturing, sciences and technology. He has an extensive background in project management in particular in petroleum and geophysical exploration in Australia, New Zealand, Libya, Nigeria, the UK, Mozambique and Iran. He holds formal qualifications in Applied Physics (BSc.) and has a Masters of Business Administration. He also holds a professional certificate in arbitration and mediation and is a graduate of the Australian Institute of Company Directors (GAICD). Keith’s main interests are in climate change research, renewable energy (biofuels), start-up companies, new technology, and the share market.

David Saint (Board member)

David Saint is an Associate Professor in the School of Molecular and Biomedical Sciences at the University of Adelaide, researching cardiovascular disease. He holds a PhD in Physiology and Pharmacology and has published over 60 research papers. In 2003 he obtained an MBA from the University of Adelaide. From 1987 to 1995, he was a Research Fellow at the John Curtin School of Medical Research in Canberra. He also worked as a toxicologist with the TGA in 1995/6 before moving to Adelaide in 1997. David has been the national secretary of the International Society for Heart Research and is a member of the NHMRC grant review panel (Pharmacology). David was the CEO and co-founder of Rhinopharma Ltd., now re-listed as Verona Pharmaceuticals on the AIM exchange in London.

Corinna Steeb (Secretary)

Corinna Steeb is the Executive Officer for Bioangels Inc. She holds qualification in Medical Sciences (PhD), is a graduate member of the Australian Institute of Company Directors (GAICD) and a Certified Professional Manager (AIM). Corinna has held research positions (CRC Tissue Growth and Repair) before changing to a career in business management. Her senior management positions include CEO of NPA , COO of Jurlique International and General Manager, Longview Vineyards. Corinna is the founder and Executive Director of Rubys CBS, a business consultant to small and medium businesses & project management service that assists private SME’s to become sustainable and grow via strategic planning, procedure implementation, sales, marketing, finance management and capital raising. Corinna works across broad Industry sectors including food, wine and beverages, cosmetics/nutroceutical, biotechnology, R&D, agricultural products, manufacturing and production. Corinna has vast experiences in the development of import /export, associated regulatory issues, logistics and transport management, joint venture development as well as R&D, technology transfer and international business development.